This study tests an oral chemotherapy drug called CC-486 (azacitidine) in 11 adults with a rare type of leukemia (T-LGLL) that has returned or not responded to prior treatments. The goal is to find the best dose and see if the drug can shrink or control the cancer. Participants w…
Phase: PHASE1, PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Jun 17, 2026 05:43 UTC